Target intelligence / Profile preview

Immune system and neuroinflammatory microenvironment

Molecular classification
Other
01

Overview

The immune system and neuroinflammatory microenvironment represent the collective cellular and molecular components within the central nervous system (CNS) that mediate inflammatory responses. This environment is primarily composed of resident glial cells, such as microglia and astrocytes, as well as infiltrating peripheral immune cells like T-cells and B-cells (Source: PMID: 30223474). Under physiological conditions, these components maintain CNS homeostasis and support neuronal health; however, chronic dysregulation leads to neuroinflammation, a hallmark of neurodegenerative diseases like Alzheimer's and Multiple Sclerosis (Source: StatPearls, Neuroinflammation). Therapeutic intervention typically focuses on modulating specific pathways within this environment—such as cytokine signaling or cellular trafficking—to mitigate neurotoxicity and promote a neuroprotective state (Source: Nature Reviews Drug Discovery). Because it encompasses a vast network of interacting cells and signaling molecules, it is considered a therapeutic landscape or system rather than a single molecular target.

Other names
Neuroinflammatory microenvironmentCNS immune environmentNeuro-immune systemNeuroinflammationBrain immune microenvironment
02

Mechanism of action

Modulation of the neuroinflammatory milieu through the inhibition of leukocyte migration, depletion of specific immune cell subsets (e.g., B-cells), or alteration of microglial and astrocytic activation states to reduce pro-inflammatory cytokine production.

03

Biological functions

Immune responseNeuroinflammationHomeostasisSynaptic pruningNeuroprotectionLeukocyte trafficking
04

Disease associations

Neurodegenerative diseaseInflammationMultiple sclerosisAlzheimer's diseaseParkinson's diseaseAmyotrophic lateral sclerosisStrokeTraumatic brain injury
05

Safety considerations

Systemic immunosuppressionIncreased risk of opportunistic infections (e.g., Progressive Multifocal Leukoencephalopathy)Potential for impaired physiological tissue repairBlood-brain barrier integrity disruptionCytokine release syndrome
06

Interacting drugs

Natalizumab

6 more in the full profile.

07

Biomarkers

Glial fibrillary acidic protein (GFAP)Neurofilament light chain (NfL)Translocator protein (TSPO) PET imagingInterleukin-6 (IL-6)Tumor necrosis factor-alpha (TNF-alpha)Soluble TREM2 (sTREM2)

Beyond the preview

Go deeper on Immune system and neuroinflammatory microenvironment.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immune system and neuroinflammatory microenvironment.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call